| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $140K | -15.1% |
| R&D Expense | $8.4M | +16.9% |
| SG&A Expense | $9.5M | +39.7% |
| Operating Income | -$17.8M | -28.6% |
| Pre-tax Income | -$17.5M | -26.0% |
| Income Tax | $93K | +2219.8% |
| Net Income | -$17.6M | -26.6% |
| EPS (Basic) | -$1.48 | -8.0% |
| EPS (Diluted) | -$1.48 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.3M | -80.2% |
| Short-term Investments | $12.8M | — |
| Current Assets | $21.1M | -44.1% |
| Total Assets | $24.1M | -38.2% |
| Current Liabilities | $4.1M | +61.6% |
| Long-term Debt | $603K | -13.1% |
| Total Liabilities | $5.2M | +25.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.7M | -18.8% |
| Investing Cash Flow | -$14.8M | — |
| Financing Cash Flow | -$79K | -100.2% |
| -8.0% |
| Stockholders' Equity |
| $18.9M |
| -45.8% |